Northwest Biotherapeutics, NHSBT announce DCVax-L production collaboration

Northwest Biotherapeutics said it has entered a collaboration with the UK National Health Service Blood and Transplant to support production of its experimental DCVax-L cancer vaccine. The work initially involves Leeds and Oxford, with plans to expand the model to additional NHSBT locations across England.